CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raptis, L.
Right arrow Articles by Haliotis, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raptis, L.
Right arrow Articles by Haliotis, T.

Cell Growth & Differentiation, Vol 8, Issue 1 11-21, Copyright © 1997 by American Association of Cancer Research


ARTICLES

Ras(leu61) blocks differentiation of transformable 3T3 L1 and C3H10T1/2-derived preadipocytes in a dose- and time-dependent manner

L Raptis, J Yang, H Brownell, J Lai, T Preston, MJ Corbley, RP Narsimhan and T Haliotis
Department of Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada.

To investigate the functional relationship between the transforming ability of Ras and its role as an integral component of the differentiation-promoting insulin signaling pathway, we introduced a leu61-activated ras gene into the Ras-transformable 3T3 L1 (ATCC CCL92.1) and a number of C3H10T1/2-derived preadipocytic cell lines. The results demonstrate a quantitative reciprocal regulation of differentiation and several transformation-associated properties in response to graded levels of ras gene expression, with the loss of differentiative capacity, morphological transformation, stimulation of proliferation, and anchorage-independent growth requiring increasing levels of Ras(leu61) protein. Furthermore, using novel, tightly regulatable 3T3 L1 transfectants, we demonstrated that Ras(leu61) effectiveness in blocking adipocytic differentiation is strictly dependent on the timing of its expression relative to cell growth arrest, with ras(leu61) expression being ineffective at inhibiting differentiation or inducing morphological transformation once the differentiative process has commenced. Moreover, rasleu61 induction failed to substitute for or enhance the c-Ras-dependent differentiative insulin signal, even under conditions in which it did not induce transformation. Therefore, although necessary for insulin signal transduction, the Ras signal alone is not sufficient to induce adipocytic differentiation in this system. Consistent with its established role as a downstream effector of Ras, v-Raf expression mirrored the Rasleu61 effects on adipocytic differentiation and transformation.


This article has been cited by other articles:


Home page
Anticancer ResHome page
R. ARULANANDAM, M. GELETU, and L. RAPTIS
The Simian Virus 40 Large Tumor Antigen Activates cSrc and Requires cSrc for Full Neoplastic Transformation
Anticancer Res, January 1, 2010; 30(1): 47 - 53.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Vultur, R. Arulanandam, J. Turkson, G. Niu, R. Jove, and L. Raptis
Stat3 Is Required for Full Neoplastic Transformation by the Simian Virus 40 Large Tumor Antigen
Mol. Biol. Cell, August 1, 2005; 16(8): 3832 - 3846.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J. B. Hansen, R. K. Petersen, C. Jorgensen, and K. Kristiansen
Deregulated MAPK Activity Prevents Adipocyte Differentiation of Fibroblasts Lacking the Retinoblastoma Protein
J. Biol. Chem., July 19, 2002; 277(29): 26335 - 26339.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
N. Grammatikakis, A. Vultur, C. V. Ramana, A. Siganou, C. W. Schweinfest, D. K. Watson, and L. Raptis
The Role of Hsp90N, a New Member of the Hsp90 Family, in Signal Transduction and Neoplastic Transformation
J. Biol. Chem., March 8, 2002; 277(10): 8312 - 8320.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
I. Manni, G. Mazzaro, A. Gurtner, R. Mantovani, U. Haugwitz, K. Krause, K. Engeland, A. Sacchi, S. Soddu, and G. Piaggio
NF-Y Mediates the Transcriptional Inhibition of thecyclin B1, cyclin B2, and cdc25CPromoters upon Induced G2 Arrest
J. Biol. Chem., February 23, 2001; 276(8): 5570 - 5576.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
I. Manni, G. Mazzaro, A. Gurtner, R. Mantovani, U. Haugwitz, K. Krause, K. Engeland, A. Sacchi, S. Soddu, and G. Piaggio
NF-Y Mediates the Transcriptional Inhibition of thecyclin B1, cyclin B2, and cdc25CPromoters upon Induced G2 Arrest
J. Biol. Chem., February 23, 2001; 276(8): 5570 - 5576.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.